Atorvastatin for lowering lipids
6 results
1 - 6
Intensive lipid lowering reduces mortality following ACS- Lipid lowering is beneficial for secondary prevention but not primary prevention in patients 75 years and older
- Atorvastatin = placebo for primary prevention of CV events in patients with rheumatoid arthritis
- Lipid targets for kids: limited data
- No benefit to addition of stenting for treatment of atherosclerotic renal artery stenosis